Physician profile
Carlayne E Jackson
NPI 1083620967
$77,214.19
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62K · 2020: $4,302 · 2021: $3,300 · 2022: $5,225 · 2023: $2,778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,750 · Education: $28.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,750.00 |
| Education | $28.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma America, INC. | $40,865.31 | 2019-2023 | |
| Csl Behring | $14,263.96 | 2019 | |
| Mitsubishi Tanabe Pharma Development America, INC. | $7,425.00 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $6,357.78 | 2019 | |
| Avanir Pharmaceuticals, INC. | $3,948.72 | 2019 | |
| Mallinckrodt Enterprises LLC | $3,487.50 | 2019 | |
| Mdd US Operations, LLC | $500.00 | 2020 | |
| Strongbridge US INC. | $295.38 | 2019 | |
| Grifols Shared Services North America, INC. | $70.54 | 2020 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlayne Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.